We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
158 hedge funds and large institutions have $320M invested in ANI Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 62 increasing their positions, 40 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
55% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 40
29% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 24
1.68% more ownership
Funds ownership: 54% → 55.68% (+1.7%)
1% more funds holding
Funds holding: 157 → 158 (+1)
16% less capital invested
Capital invested by funds: $379M → $320M (-$59.7M)
85% less call options, than puts
Call options by funds: $2.71M | Put options by funds: $18M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
158
Holders Change
+1
Holders Change %
+0.64%
% of All Funds
3.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
62
Reduced
40
Closed
24
Calls
$2.71M
Puts
$18M
Net Calls
-$15.3M
Net Calls Change
-$12.1M
Top Buyers
| 1 |
BlackRock
New York
|
+$63.5M |
| 2 |
First Manhattan
New York
|
+$15.6M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.83M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.61M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$3.28M |
